Sign Up
bf/NASDAQ:ELEV_icon.jpeg

COM:ELEVATIONONCOLOGY

Elevation Oncology, Inc.

  • Stock

Last Close

0.58

21/11 21:00

Market Cap

144.25M

Beta: -

Volume Today

480.58K

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
3.07M
-
5.66M
84.51%
6.00M
6.03%
3.43M
42.81%
average receivables
book value per share
-1.40
-
11.60
930.86%
2.11
81.83%
0.00
99.92%
capex per share
-0.00
-
-0.00
-
capex to depreciation
-4.73
-
-3.19
-
capex to operating cash flow
0.01
-
0.00
-
capex to revenue
cash per share
4.80
-
12.06
151.11%
3.88
67.82%
0.00
99.94%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.31
-
0.34
8.21%
debt to equity
0.60
-
0.55
8.41%
dividend yield
earnings yield
-0.09
-
-0.44
380.66%
-4.30
880.61%
-0.00
99.94%
enterprise value
-1.74M
-
109.78M
6,409.21%
-73.25M
166.72%
5.62M
107.68%
18.28B
325,075.40%
enterprise value over ebitda
-6.36
-
2.29
135.96%
-0.06
102.60%
-402.26
676,432.26%
ev to operating cash flow
-8.93
-
2.43
127.20%
-0.07
102.71%
-325.39
494,684.06%
ev to sales
free cash flow per share
-0.75
-
-2.49
232.42%
-3.68
47.91%
-0.00
99.96%
free cash flow yield
-0.07
-
-0.41
531.72%
-3.87
837.28%
-0.00
99.92%
graham net net
-1.49
-
11.33
862.14%
1.94
82.88%
0.00
99.93%
graham number
5.73
-
26.25
358.42%
13.92
46.97%
0.01
99.95%
income quality
0.71
-
0.94
32.19%
0.90
4.51%
1.23
36.72%
intangibles to total assets
0
-
0
0
0
0
interest coverage
-197.39
-
interest debt per share
1.29
-
0.00
99.93%
inventory turnover
invested capital
0.60
-
0.55
8.41%
market cap
189.18M
-
73.04M
61.39%
22.10M
69.74%
18.30B
82,690.02%
net current asset value
-5.87M
-
-23.20M
295.06%
140.63M
706.10%
47.85M
65.98%
53.68M
12.19%
net debt to ebitda
4.60
-
4.57
0.71%
0.17
96.18%
0.42
141.33%
net income per share
-1.04
-
-2.64
152.93%
-4.09
54.75%
-0.00
99.97%
operating cash flow per share
-0.74
-
-2.49
234.34%
-3.67
47.76%
-0.00
99.96%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.21
-
-0.21
0.43%
-1.01
371.15%
-0.51
49.20%
revenue per share
roe
0.75
-
-0.23
130.44%
-1.94
751.56%
-0.83
57.00%
roic
0.75
-
-0.23
130.43%
-1.21
429.17%
-0.54
55.58%
sales general and administrative to revenue
shareholders equity per share
-1.40
-
11.60
930.86%
2.11
81.83%
0.00
99.92%
stock based compensation to revenue
tangible asset value
-5.87M
-
-23.08M
293.00%
140.70M
709.58%
49.03M
65.15%
54.81M
11.78%
tangible book value per share
-1.40
-
11.60
930.86%
2.11
81.83%
0.00
99.92%
working capital
1.32M
-
74.00M
5,518.91%
140.63M
90.04%
77.28M
45.05%
83.82M
8.45%

All numbers in (except ratios and percentages)